- Joined
- 8 January 2015
- Posts
- 273
- Reactions
- 5
At a market cap of $300 million (and with $128 mill in cash), I think IMF is trading very cheaply at the moment.
I agree with that. I worked out the other day that IMF has a present earnings yield of 13% based on its average earnings for the past 5 years. If you factor in the dividends that it pays, that is a yield of well over 15%.
How are they managing in Hong Kong? There notice indicates a third investment there and a spike from the relentless down trend.Yep, plus lots of positive signs from their expansions into the US. HK and EU seem to be going ok too.
I think this Bank Fees case is providing a good opportunity to find a very low entry point.
I agree with that. I worked out the other day that IMF has a present earnings yield of 13% based on its average earnings for the past 5 years. If you factor in the dividends that it pays, that is a yield of well over 15%.
Are you sure? IMF P&L over last 5 (and a half) years
FY15 H1 $23.01m
FY14 $9.868m
FY13 $13.814m
FY12 $42.966m
FY11 $22.86m
FY10 $11.896m
So let's just take FY15 full year to be $30m, the average of the last 5 years = $23.9m. Current market cap = $288.5m so earnings yield = 8.28%.
Dividend yield comes from earnings yield so shouldn't be double counted.
With a post like that you'll fit in perfectly over at the pairs threadBought some more. These guys seem to be getting dragged down by SGH (as does SHJ), but they're completely different sort of businesses.
Bought some more. These guys seem to be getting dragged down by SGH (as does SHJ), but they're completely different sort of businesses.
Are you sure it's not because of the uncertainty (or maybe lack of faith by the market) regarding their expansion into the US and Europe?Bought some more. These guys seem to be getting dragged down by SGH (as does SHJ), but they're completely different sort of businesses.
I also noticed that they experienced a few case losses in 2H 2015. These are of course part of the long term nature of this business (good years, bad years), but they'd had a pretty immaculate record since listing up until then.
It's not the easiest investment in the world to understand and value, so I guess if you add them all up they would impact short/medium term sentiment.
A lot of the market's perception of this company's value is under-pinned by the level of trust in management as good case portfolio managers.
Always good to hear your thoughs, ves.
Summary from Lincoln indicators stock doctor
IMF exhibits unacceptable levels of financial risk due to a below benchmark Financial Health score. Investors need to be aware such companies pose risks and warrant a speculative investment only...
The STIP metrics set for the 2016 financial year are
as follows:
The STIP has been set at 35% of TFR.
Three financial targets have been set, as follows:
Target 1 – 30% of the STIP opportunity (or 10.5% of the employees’ salary) will be awarded to employees if the Group achieves 5% growth in global net profit before tax (before bonus);
Target 2 – 30 % of the STIP opportunity (or 10.5% of the employees’ salary) will be awarded if the employees’ region achieves 5% growth in net profit before tax (before bonus);
Target 3 – 20% of the STIP opportunity (or 7% of the employees’ salary) will be awarded if the Group achieves 5% growth in the total claim value of the investment portfolio
... However, it seems Saker (MD) has no holdings in the company, and a 20% of his Short term incentive coming from an increase in case loads of 5%. Is this the reason for the recent increase in cases? (maybe it only appears that way to me)...
Hugh McLernon the previous MD controls around 5mil shares. He was not ready to retire but when the opportunity to employ Mr Sakir came along was more than happy to step aside.
Thanks Robusta. May I ask where you found out that bit of information (bolded)?
I looked through the investor presentation prior to his appointment, and the Board Changes announcement on 05/01/15 and didn't find anything indicating this. I've clearly missed it somewhere.
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?